Skip to main content
. 2017 May 15;2017:7802672. doi: 10.1155/2017/7802672

Table 1.

Summary of study results.

US group
(n = 57)
FS group
(n = 57)
Statistical analysis
Factors influencing SWL outcome

Stone-related factors
Stone size
Mean stone size (mm)(1) 9 (σ = 3) 8.5 (σ = 3) p = 0.29
Number of stones 0–4 mm 5 5 p = 1
Number of stones 5–9 mm 30 30 p = 1
Number of stones 10–20 mm 22 22 p = 1
Stone composition (2)
Number of hard stones(3) 6 (n = 30) 4 (n = 25) p = 0.50
Stone position
Number of lower pole stones 22 (39%) 22 (39%) p = 1
Number of pyelum and PUJ stones 5 (9%) 8 (14%) p = 0.37
Number of upper pole stones 18 (31%) 8 (14%) p = 0.02
Number of midpolar stones 12 (21%) 19 (33%) p = 0.14
Stone density (HU) (4)
Mean stone density (HU) 665 (σ = 160, n = 31) 740 (σ = 223, n = 29) p = 0.10
Maximal stone density (HU) 965 1213 NA

Operator-related factors
Experience with both techniques 2 investigators with equal experience NA

Patient-related factors
Mean BMI (kg/m2) 27 (σ = 3,8) 29 (σ = 3,3) p = 0.001
Mean skin-to-stone distance (mm)(5) 90 (σ = 13, n =31) 104 (σ = 14, n = 29) p < 0.001

Technique-related factors
Shock frequency (bpm) 60 p = 1
Number of shocks 2500 p = 1
Ramping protocol Identical in both groups NA
Mean energy (Joule) 49 (σ = 11) 53 (σ = 11) p = 0.002

Study outcomes

Clinical outcome
Number of stone-free patients 30 24 Noninferior(6)
Number of patients with asymptomatic residual fragments 15 16
Number of patients with a positive outcome(7) 45 40 Noninferior(6)
Number of patients needing additional therapy 6 9
Number of patients with no effect 6 8
Number of patients with a negative outcome(8) 12 17 Noninferior(6)

Number of ESWL sessions
Mean number of SWL sessions/patient 1.6 (σ = 0,7) 1.7 (σ = 0,7) p = 0.431

Positioning
Mean number of position changes/patient 8 (σ = 2) 6 (σ = 2) p = 0.008
Mean time to position/patient 9 (σ = 2) 5 (σ = 2) p < 0.001

Radiation
Mean DAP (mGy/cm2)/SWL session 0 3005 (σ = 601) p < 0.001

(1) Measured as longest stone distance on RX before the first SWL session. (2) Only 55/114 (48%) patients analysed their stone. (3) Calcium oxalate monohydrate (whewellite), cystine, or calcium phosphate (brushite) stones. (4) Hounsfield units as measured on CT abdomen. (5) Measured vertically in the US group and 45° in the FS group. (6) With a noninferiority margin of 10%. (7) Stone-free or asymptomatic residual fragments ≤ 4 mm. (8) Additional therapy or no effect.